Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20884625

Clin. Cancer Res. 2010 Nov 15 16 22 5424-35

Download in:

View as

General Info

PMID
20884625